Erlotinib intercalating pemetrexed/cisplatin versus erlotinib alone in Chinese patients with brain metastases from lung adenocarcinoma: a prospective, non-randomised, concurrent controlled trial (NCT01578668)
- Resource Type
- Article
- Source
- In
ESMO Open 2017 2 Supplement 1 - Subject
- Language
- ISSN
- 2059-7029